- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05012657
Validation of Point Partial User Needs With Partial Finger Amputees
August 21, 2024 updated by: Point Designs
The objective of the device feasibility study will be to validate the user needs of the Point Partial system.
This study will be a single group intervention model where one group of 5 partial finger amputees will be asked to perform several tasks.
Successful completion of a task results in a fulfilled user need.
Failure to complete a task results in an unfulfilled user need.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045
- University of Colorado Denver | Anschutz Medical Campus
-
Lafayette, Colorado, United States, 80026
- Point Designs
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Partial finger amputees with partial absence of index and/or middle fingers and presence of thumb. Additional finger loss is acceptable if all other criterion are met.
- Fluent in English
- Individuals aged 18 or greater
- Patients may present with either fused or mobile MCP joints.
Exclusion Criteria:
- Significant cognitive deficits as determined upon clinical evaluation
- Significant neurological deficits as determined upon clinical evaluation
- Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
- Uncontrolled pain or phantom pain impacting full participation in the study as determined upon OT evaluation
- Serious uncontrolled medical problems as judged by the project therapist.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prosthesis
Patient is temporarily fit with Point Partial partial finger prosthetic system
|
The Point Partial partial finger prosthetic system consists of 1-4 ratcheting mechanical partial digits and mounting brackets
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VAL-1: System Comfort Validation Test
Time Frame: Day 1 (8 hours)
|
User wears Point Partial(s) for a full day (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall be comfortable for a full day's use.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (8 hours)
|
|
VAL-2: Unilateral Function Validation Test
Time Frame: Day 1 (10 minutes)
|
User flexes and extends the Point Partial(s) without using contralateral hand (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall allow the user to flex and extend finger without their second hand.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-3.1: System Robustness Validation Test With 25 lb Bag
Time Frame: Day 1 (10 minutes)
|
User lifts a 25 lb.
bag with Point Partial(s) (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall be robust enough to operate in challenging environments.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-3.2: Robustness Validation Test With Hammer
Time Frame: Day 1 (10 minutes)
|
User grips a hammer with Point Partial(s) and drives a nail into a piece of wood (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall be robust enough to operate in challenging environments.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-4: Object Release Validation Test
Time Frame: Day 1 (10 minutes)
|
User releases Point Partial(s) while performing an active grasp by pressing the dorsal button (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall be releasable while performing active grasps.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-5: Position Function Validation Test
Time Frame: Day 1 (10 minutes)
|
User positions Point Partial(s) into each of the locking positions (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall have a smooth ratcheting mechanism.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-6: Extension Function Validation Test
Time Frame: Day 1 (10 minutes)
|
User activates spring-back mechanism by using (1) contralateral hand, (2) tabletop, and (3) side or thigh throughout day without failed extension (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall have a reliable auto spring-back mechanism.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-7: Grip Functions Validation Test
Time Frame: Day 1 (10 minutes)
|
User grips a 5 lb.
cylindrical smooth object using Point Partial(s) for 10 seconds (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall have high grip surface friction.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-8: Fine Motor Function Validation Test
Time Frame: Day 1 (10 minutes)
|
User picks up 1 coin from a smooth tabletop (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall have a pronounced fingernail.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (10 minutes)
|
|
VAL-9: Overall Function & Robustness Validation Test
Time Frame: Day 1 (8 hours)
|
User performs VAL-1 through VAL-8 (Pass/Fail).
This validation method was used to confirm the following user need of the Point Partial has been met: Point Partial shall be robustly attached to mounting system.
A simple pass/fail result was recorded for each user need for each participant.
An overall passing rate above 80% across all user needs and participants is considered a success.
Each participant attended a single-day experimental session.
A day-use prosthetic socket was fabricated and Point Partials were mounted to the socket.
Then, each participant attempted the validation test.
|
Day 1 (8 hours)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 3, 2020
Primary Completion (Actual)
December 31, 2022
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
August 12, 2021
First Submitted That Met QC Criteria
August 12, 2021
First Posted (Actual)
August 19, 2021
Study Record Updates
Last Update Posted (Estimated)
November 8, 2024
Last Update Submitted That Met QC Criteria
August 21, 2024
Last Verified
August 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 299089
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amputation; Traumatic, Hand
-
Shirley Ryan AbilityLabEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruitingAmputation; Traumatic, Hand, and Wrist | Amputation; Traumatic, Hand, at Wrist LevelUnited States
-
Shirley Ryan AbilityLabUniversity of AlbertaActive, not recruitingAmputation | Amputation; Traumatic, Hand | Amputation, Traumatic | Amputation; Traumatic, LimbUnited States
-
Boninger, Michael, MDNational Institute of Neurological Disorders and Stroke (NINDS); Ripple Therapeutics...RecruitingAmputation | Amputation; Traumatic, HandUnited States
-
Liberating Technologies, Inc.Össur Iceland ehfCompletedAmputation | Prosthesis User | Amputation; Traumatic, Hand | Upper Limb Amputation at the Hand | Limb; Absence, Congenital, UpperUnited States
-
Martin BerliBern University of Applied SciencesCompletedAmputation; Traumatic, HandSwitzerland
-
Point DesignsUniversity of Colorado, Denver; National Institute of Neurological Disorders... and other collaboratorsNot yet recruitingAmputation; Traumatic, HandUnited States
-
Centre hospitalier de l'Université de Montréal...RecruitingAmputation; Traumatic, HandCanada
-
Centre hospitalier de l'Université de Montréal...RecruitingAmputation; Traumatic, HandCanada
-
Point DesignsUniversity of Colorado, Denver; Arm DynamicsCompletedAmputation; Traumatic, HandUnited States
-
Point DesignsUniversity of Colorado, Denver; Eunice Kennedy Shriver National Institute of...CompletedAmputation; Traumatic, HandUnited States
Clinical Trials on Point Partial
-
Point DesignsUniversity of Colorado, Denver; Arm DynamicsCompletedAmputation; Traumatic, HandUnited States
-
Point DesignsUniversity of Colorado, Denver; National Institute of Neurological Disorders... and other collaboratorsNot yet recruitingAmputation; Traumatic, HandUnited States
-
Menoufia UniversityRecruiting
-
University Health Network, TorontoWithdrawn
-
Marshall UniversityArthrex, Inc.; Medstar Washington Hospital CenterRecruitingMeniscus TearUnited States
-
South Valley UniversityCompletedTrifecta Achievement | Pentafecta AchievementEgypt
-
Saint Petersburg State University, RussiaCompletedRenal Tumor | Renal Malignant TumorRussian Federation
-
Rabin Medical CenterUnknownTumor | Laparoscopy | NephrectomyIsrael
-
University Hospital, CaenTerminatedDeep Vein ThrombosisFrance
-
Hospital de Clinicas de Porto AlegreCompletedDeviated Nasal Septum | Nasal Septal Defect | Nasal Septum, IrregularBrazil